The reSET-O prescription medical application is a 12-week software application providing cognitive behavioral therapy as a support to outpatient treatment.
Keystone
Sandoz Inc., a division of Swiss pharmaceutical giant Novartis, and US company Pear Therapeutics announced this week that the the U.S. Food and Drug Administration (FDA) has approved an app that can be prescribed to help treat opium addicts.
This content was published on
2 minutes
For patients 18 years or older who are currently under the supervision of a clinician, reSET-O is indicated as a prescription-only mobile medical application, Novartis noted in a media statementExternal link.
As a digital therapist, the app is intended to protect patients from relapses with interactive dialogues. Every day, approximately 115 Americans die after overdosing on opioids.
“Digital technologies and data science have incredible potential to unlock the next chapter of medical innovation and to help individuals finally take control of their own health in a meaningful way,” said Sandoz CEO Richard Francis. “New digital therapeutics such as reSET-O also have the potential to fundamentally change how patients interact with their therapies and thus improve patient outcomes. At Sandoz, we are proud to be a joint pioneer in this exciting new field.”
The Novartis generics subsidiary SandozExternal link is responsible for marketing the application prescribed by the physician. In the spring, Sandoz signed a cooperation agreement with Pear TherapeuticsExternal link. Sandoz says it hopes to be able to charge $15 (CHF15) per month for the app. However, the price is not yet definite, the NZZ am Sonntag reported.External link
The US regulatory authority has been convinced by its success. Over 12 weeks, 170 patients participated in an opiate withdrawal program. All received a replacement drug. However, 82.4% of those who used the app remained in the program. In the group without a supportive app, only 68.4% managed the full three months, the FDA reported in a press release.
In the United States, 48.5 million people are addicted to drugs. About 18.5% of the adult population consume illegal drugs such as heroin or abuse legal substances such as painkillers. Alcoholics are not included in the figures.
The statistics also reflect the devastating opium dependence of broad sections of the population. The problem is widely blamed on the lax prescription practice of new, supposedly non-addictive painkillers since the 1990s. The “economic burden” of this epidemic amounts to $78.5 billion annually, according to the Centers for Disease Control and PreventionExternal link.
Popular Stories
More
Foreign Affairs
How a top Swiss university is screening Chinese students
Two decades after tsunami, Swiss tourists flock to Southeast Asia
This content was published on
Twenty years after a catastrophic tsunami in Southeast Asia, the region is again a top destination for Swiss, including at Christmas.
Swiss forests better equipped for storms 25 years after Lothar
This content was published on
Twenty-five years after Hurricane Lothar wreaked havoc in Switzerland, the country’s forests are now better prepared, experts say.
Media: Swiss medical services done abroad are billed at Swiss rates
This content was published on
In Switzerland, some medical services carried out abroad are still billed at Swiss rates, despite costing less, RTS reports.
This content was published on
Sophie Hediger, a member of the Swiss national snowboard cross team, has died in an avalanche in Arosa. She was 26 years old.
This content was published on
Several Swiss films exceeded the 100,000 admissions mark worldwide in 2024 and received widespread praise at international film festivals.
Swiss Alpine resorts covered in white gold for Christmas
This content was published on
Many areas at low altitudes in Switzerland are enjoying a blanket of snow. In the mountains, intense precipitation has delighted skiers.
SWISS makes emergency landing in Austria after smoke in cockpit
This content was published on
Swiss International Airlines (SWISS) made an emergency landing of an Airbus in Graz, Austria on Monday evening after engine problems.
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.
Read more
More
Novartis to cut 2,200 Swiss jobs by 2020
This content was published on
Around 1,500 jobs are affected in production and 700 in services. Novartis currently employs 13,000 people across Switzerland.
Too few pharma companies prioritise access to medicines
This content was published on
Novartis and Roche both get a boost in the 2018 ranking of progress in expanding access to medicines by the biggest pharmaceutical companies.
Pharma companies put faith in AI for breakthroughs
This content was published on
Global pharmaceutical companies are increasingly turning to artificial intelligence to develop new drugs. But this may not soon lead to lower prices.
You can find an overview of ongoing debates with our journalists here . Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.